Needham keeps Buy on Xenon Pharmaceuticals, $60 price target
Needham maintained a Buy rating on Xenon Pharmaceuticals and reiterated a $60.00 price target, implying 4.6% upside versus the Sep 17 close of $57.35.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.